MedPath
HSA Product

Lormalzi Concentrate for Solution for Infusion 350mg/20mL

Product approved by Health Sciences Authority (SG)

Basic Information

Lormalzi Concentrate for Solution for Infusion 350mg/20mL

INFUSION, SOLUTION CONCENTRATE

Regulatory Information

SIN17201P

March 11, 2025

Prescription Only

Therapeutic

INTRAVENOUS

May 23, 2025

June 4, 2025

Company Information

Lilly France

DKSH SINGAPORE PTE. LTD.

Active Ingredients

Donanemab

Strength: 350mg/20mL

© Copyright 2025. All Rights Reserved by MedPath